Select Page
Adoram Therapeutics SA wins stage 1 venture kick

Adoram Therapeutics SA wins stage 1 venture kick

Adoram management presented before an expert panel for the stage I venture kick startup competition. The concept of Leveraging allosteric biochemistry for patients was found convincing by the jury and was granted 10K CHF. For further details, please refer to the...
Sachs’ 16th Annual European Life Sciences CEO forum

Sachs’ 16th Annual European Life Sciences CEO forum

We are heading to Sachs’ 16th Annual European Life Sciences CEO forum to discuss the latest data package generated by Adoram Therapeutics. Not only do we show superior efficacy, but more importantly improved safety compared to competitors thanks to our unique MoA....
Adoram is in BioEurope in Munich

Adoram is in BioEurope in Munich

First day in BioEurope and everyone can already feel the enthusiasm about the market not only stabilizing but showing strong recovery trends. If you are around, let’s have a chat over a coffee. Alot of developments took place over the last year for Adoram...
Meet us at upcoming events

Meet us at upcoming events

One or more representatives from Adoram Therapeutics will be attending the events listed below. Please feel free reach out via the contact form, email, or linkedin, if you would like to organize a meeting there.  November:  Swiss Oncology and Hematology...
Adoram is attending BioEurope Leipzig

Adoram is attending BioEurope Leipzig

Co-founders David Pejoski and Hesham Hamed will attend one of the premier biotech partnering events in Europe, the autumn edition of BioEurope, to be held in Leipzig Germany between the 24th and 26th October 2022. This networking event brings together young biotech...